{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:37:41Z","timestamp":1786372661682,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>The relationship between mineral and bone disorders and survival according to residual kidney function status has not been previously studied in patients on hemodialysis. We hypothesized that residual kidney function, defined by renal urea clearance, modifies the association between mineral and bone disorder parameters and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>\n                      The associations of serum phosphorus, albumin-corrected calcium, intact parathyroid hormone, and alkaline phosphatase with all-cause mortality were examined across three strata (&lt;1.5, 1.5 to &lt;3.0, and \u22653.0 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ) of baseline residual renal urea clearance using Cox models adjusted for clinical characteristics and laboratory measurements in 35,114 incident hemodialysis patients from a large United States dialysis organization over the period of 2007\u20132011.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 8102 (23%) patients died during the median follow-up of 1.3 years (interquartile range, 0.6\u20132.3 years). There was an incremental mortality risk across higher serum phosphorus concentrations, which was pronounced among patients with higher residual renal urea clearance (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      =0.001). Lower concentrations of serum intact parathyroid hormone were associated with higher mortality among patients with low residual renal urea clearance (\n                      <jats:italic toggle=\"yes\">i.e.<\/jats:italic>\n                      , &lt;1.5 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ), whereas higher concentrations showed a higher mortality risk among patients with greater residual renal urea clearance (\n                      <jats:italic toggle=\"yes\">i.e.<\/jats:italic>\n                      , \u22651.5 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      &lt;0.001). Higher serum corrected total calcium and higher alkaline phosphatase concentrations consistently showed higher mortality risk (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>trend<\/jats:sub>\n                      &lt;0.001 for both) irrespective of residual renal urea clearance strata (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      =0.34 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      =0.53, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Residual kidney function modified the mortality risk associated with serum phosphorus and intact parathyroid hormone among incident hemodialysis patients. Future studies are needed to examine whether taking account for residual kidney function into the assessment of mortality risk associated with serum phosphorus and intact parathyroid hormone improves patient management and clinical outcomes in the hemodialysis population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.11931116","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T20:30:27Z","timestamp":1494361827000},"page":"1118-1127","source":"Crossref","is-referenced-by-count":32,"title":["Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function"],"prefix":"10.2215","volume":"12","author":[{"given":"Mengjing","family":"Wang","sequence":"first","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California;"},{"name":"Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Obi","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elani","family":"Streja","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Rhee","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Ling","family":"Lau","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanming","family":"Hao","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hamano","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Kidney Disease Research, Osaka University Graduate School of Medicine, Osaka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee;"},{"name":"Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, Tennessee;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California;"},{"name":"Department of Epidemiology, Fielding School of Public Health at University of California, Los Angeles, Los Angeles, California; and"},{"name":"Nephrology Section, Tibor Rubin Veterans Affairs Medical Center, Long Beach, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"B1-20230813","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"B2-20230813","first-page":"523","article-title":"Left ventricular hypertrophy and parathyroid hormone: A causal connection?","volume":"39","author":"Schl\u00fcter","year":"1998","journal-title":"Cardiovasc Res"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1523-1755.2003.00864.x","article-title":"Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.","volume":"63","author":"Amann","year":"2003","journal-title":"Kidney Int"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: Key roles for calcium and phosphate.","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","article-title":"Vascular calcification: An update on mechanisms and challenges in treatment.","volume":"93","author":"Wu","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.kint.2016.02.037","article-title":"Preservation of residual kidney function in hemodialysis patients: Reviving an old concept.","volume":"90","author":"Mathew","year":"2016","journal-title":"Kidney Int"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2215\/CJN.06100710","article-title":"Contribution of residual function to removal of protein-bound solutes in hemodialysis.","volume":"6","author":"Marquez","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2215\/CJN.04480510","article-title":"Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.","volume":"6","author":"Penne","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1681\/ASN.2015040426","article-title":"Long-term effects of frequent in-center hemodialysis.","volume":"27","author":"Chertow","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2015.02.331","article-title":"Long-term effects of frequent nocturnal hemodialysis on mortality: The Frequent Hemodialysis Network (FHN) nocturnal trial.","volume":"66","author":"Rocco","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.ajkd.2016.01.008","article-title":"Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: A cohort study.","volume":"68","author":"Obi","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2008.05.020","article-title":"Disordered mineral metabolism in hemodialysis patients: An analysis of cumulative effects in the Hemodialysis (HEMO) Study.","volume":"52","author":"Wald","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"B15-20230813","first-page":"S130","article-title":"Clinical practice recommendations for peritoneal dialysis adequacy.","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area.","volume":"317","author":"Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1681\/ASN.V75780","article-title":"Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics.","volume":"7","author":"Depner","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2215\/CJN.13141216","article-title":"Longitudinal associations among renal urea clearance-corrected normalized protein catabolic rate, serum albumin, and mortality in patients on hemodialysis.","volume":"12","author":"Eriguchi","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1541-0420.2008.00994.x","article-title":"A new nonparametric approach for baseline covariate adjustment for two-group comparative studies.","volume":"64","author":"Schacht","year":"2008","journal-title":"Biometrics"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1681\/ASN.2015101142","article-title":"Residual kidney function decline and mortality in incident hemodialysis patients.","volume":"27","author":"Obi","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"B22-20230813","first-page":"S2","article-title":"Clinical practice guidelines for hemodialysis adequacy, update 2006.","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2215\/CJN.00230112","article-title":"Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function.","volume":"8","author":"Wang","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"F1418","DOI":"10.1152\/ajprenal.00633.2013","article-title":"Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.","volume":"306","author":"Yamada","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MCO.0000000000000171","article-title":"Latest consensus and update on protein-energy wasting in chronic kidney disease.","volume":"18","author":"Obi","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis.","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1210\/jc.2016-1369","article-title":"Hidden hypercalcemia and mortality risk in incident hemodialysis patients.","volume":"101","author":"Obi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS).","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jbmr.3013","article-title":"Development and validation of a novel laboratory-specific correction equation for total serum calcium and its association with mortality among hemodialysis patients.","volume":"32","author":"Obi","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1681\/ASN.2014050472","article-title":"Uncorrected and albumin-corrected calcium, phosphorus, and mortality in patients undergoing maintenance dialysis.","volume":"26","author":"Rivara","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets.","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/sj.ki.5001600","article-title":"Insufficiency of PTH action on bone in uremia.","volume":"102","author":"Iwasaki","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"B36-20230813","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.1994.79","article-title":"The renal PTH\/PTHrP receptor is down-regulated in rats with chronic renal failure.","volume":"45","author":"Ure\u00f1a","year":"1994","journal-title":"Kidney Int"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia.","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.kint.2015.10.011","article-title":"Estimating residual kidney function in dialysis patients without urine collection.","volume":"89","author":"Shafi","year":"2016","journal-title":"Kidney Int"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.kint.2015.12.042","article-title":"Predicting residual kidney function in hemodialysis patients using serum \u03b2-trace protein and \u03b22-microglobulin.","volume":"89","author":"Wong","year":"2016","journal-title":"Kidney Int"},{"key":"B42-20230813","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5414\/CNP60161","article-title":"Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients.","volume":"60","author":"Kato","year":"2003","journal-title":"Clin Nephrol"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B44-20230813","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease.","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"B45-20230813","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2008.26","article-title":"Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcification.","volume":"73","author":"Lomashvili","year":"2008","journal-title":"Kidney Int"},{"key":"B46-20230813","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B47-20230813","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1523-1755.2001.00794.x","article-title":"Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.","volume":"60","author":"Magnusson","year":"2001","journal-title":"Kidney Int"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2215\/CJN.06091108","article-title":"Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients.","volume":"4","author":"Shantouf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000346846","article-title":"Vitamin D treatment and mortality in chronic kidney disease: A systematic review and meta-analysis.","volume":"37","author":"Duranton","year":"2013","journal-title":"Am J Nephrol"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","article-title":"Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies.","volume":"58","author":"Pilz","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B52-20230813","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1053\/ajkd.2001.29222","article-title":"A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.","volume":"38","author":"Kalantar-Zadeh","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B53-20230813","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1525-139X.2005.18212.x","article-title":"Adherence with dialysis: A focus on mortality risk.","volume":"18","author":"Leggat","year":"2005","journal-title":"Semin Dial"},{"key":"B54-20230813","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201707000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:36:47Z","timestamp":1786369007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201707000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11931116","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}